Glucagon is a hormone that signals the liver to release glucose into the bloodstream. It's typically given by injection to counteract severe hypoglycemia in people who have diabetes.

Altimmune’s pemvidutide failed to significantly improve fibrosis in MASH patients in a Phase IIb study. The biotech crashed ...

Testing their glucagon-packed micelles in lab experiments, the researchers found that they disassembled and released glucagon only in liquid environments that mimicked hypoglycemia in humans and ...

A dozen volunteers with severe type 1 diabetes showed clear improvements in their condition 12 months after receiving a ...

On readmission, in January, 1965, no new physical findings were evident, and it was not known whether the zinc glucagon was inactive or the worsening condition was due to progression of the disease.

A new study led by Ananda Basu, M.D., used novel non-radioactive, stable glucagon tracers for the first time to characterize glucagon metabolism in humans with and without Type 1 diabetes, providing ...

This new obesity drug acts like three hormones: glucose-depending insulinotropic polypeptide (GIP), GLP-1, and glucagon. It helps you feel full after eating less and regulates blood sugar levels ...

Three new competitors are about to launch glucagon, turning this duopoly into a potential 5-player market. Epinephrine revenues should meaningfully disappoint as shortage benefits alleviate, ...

On readmission, in January, 1965, no new physical findings were evident, and it was not known whether the zinc glucagon was inactive or the worsening condition was due to progression of the disease.